NEI Psychopharm(@neiglobal) 's Twitter Profile Photo

With treatment-resistant depression, standard treatments sometimes aren't enough. Here, Dr. Andrew Cutler and Dr. Roger McIntyre (Roger S. McIntyre, MD, FRCPC) provide an update on the current options for management of treatment-resistant depression.

account_circle
NEI Psychopharm(@neiglobal) 's Twitter Profile Photo

The enormous impact of loneliness and social isolation on psychiatric and physical well-being has become increasingly apparent, especially with the COVID pandemic. Here, Dr. Roger McIntyre (Roger S. McIntyre, MD, FRCPC) addresses how we can better assist our patients with

account_circle
Metabolic Mind(@Metabolic_Mind) 's Twitter Profile Photo

Leading academic researcher Roger S. McIntyre, MD, FRCPC is convinced that what you eat affects your brain's function.

That's why interventions like a may be able to treat and prevent psychiatric conditions. But what about drugs like Wegovy and Ozempic?

youtu.be/5u7TQ22rmO4

account_circle
Angela T.H. Kwan(@TheAngelaKwan) 's Twitter Profile Photo

Delighted to have presented our findings on the use of Vortioxetine for Post-COVID-19 Condition at in Denver, CO! 🧠 Grateful for the support from my superstar mentor, Roger S. McIntyre, MD, FRCPC!

Delighted to have presented our findings on the use of Vortioxetine for Post-COVID-19 Condition at #AAN2024 in Denver, CO! 🧠 Grateful for the support from my superstar mentor, @rogersmcintyre!

#AAN2024 #BrainHealth #AANAM #Neurology #BCDFoundation
account_circle
NEI Psychopharm(@neiglobal) 's Twitter Profile Photo

Here at , Dr. Roger McIntyre (Roger S. McIntyre, MD, FRCPC) answered additional attendee questions on his presentation. Listen to the full episode on the NEI Podcast nei.global/e202

account_circle
Metabolic Mind(@Metabolic_Mind) 's Twitter Profile Photo

Leading psychiatrist & researcher Roger S. McIntyre, MD, FRCPC believes targeting brain metabolism is key to treating many conditions, from ADHD to Bipolar to Alzheimers. That's why interventions like are so promising.

Is the same true for ?

youtu.be/5u7TQ22rmO4

account_circle
Leadwire Webcasts(@Leadwire_Talks) 's Twitter Profile Photo

We feel honored that we could talk with Roger S. McIntyre, MD, FRCPC, from UofTPsychiatry about the topic of gut microbiota in adults with bipolar disorder. The paper of this topic is published in Taylor & Francis Research Insights.
See more on: leadwire.com/stream/6295f77…

account_circle
Harish Shetty :(@DrHarish139) 's Twitter Profile Photo

Roger S. McIntyre, MD, FRCPC gave us a brilliant presentation on here at Frontiers in Psychiatry : Clear messages , high quality data & wisdom personified

Thank you so much Prof Roger

@rogersmcintyre gave us a brilliant presentation on #BIPOLARDISORDER here at Frontiers in Psychiatry : Clear messages , high quality data & wisdom personified 

Thank you so much Prof Roger
account_circle
Brain & Mental Health Conference(@BrainMenta41998) 's Twitter Profile Photo

Warm reminder: Abstract submission deadline is Mar 17th! Highlight of the keynote speaker:
Prof. Roger McIntyre is a Professor of Psychiatry and Pharmacology at the University of Toronto Roger S. McIntyre, MD, FRCPC

Warm reminder: Abstract submission deadline is Mar 17th! Highlight of the keynote speaker:
Prof. Roger McIntyre is a Professor of Psychiatry and Pharmacology at the University of Toronto #depression #treatment #mentalhealth #hksyu #brain #psychiatry #prevention @rogersmcintyre
account_circle
Boris D Heifets(@TheBorisLab) 's Twitter Profile Photo

Pretty wild case report, non-psychedelic psilocybin dose is still effective for depression ... N=1 ofc. I'd talk smack but we cured PTSD in N=1 with just a little propofol and a dream.

Non-drug factors likely key here...

Pretty wild case report, non-psychedelic psilocybin dose is still effective for depression ... N=1 ofc. I'd talk smack but we cured PTSD in N=1 with just a little propofol and a dream. 

Non-drug factors likely key here...
account_circle
Farhan Fancy, MSc(@FarhanFancy1) 's Twitter Profile Photo

Excited to share I successfully defended my MSc thesis on 💉for depression 🧠 Thank you to my supervisor Joshua Rosenblat, MD, MSc, FRCPC and comittee members Roger S. McIntyre, MD, FRCPC Ishrat Husain Dr. Rodrigo Mansur for their invaluable mentorship and guidance & my colleagues Mood Disorders Psychopharmacology Unit

Excited to share I successfully defended my MSc thesis on #ketamine 💉for #bipolar depression 🧠 Thank you to my supervisor @JD_Rosenblat and comittee members @rogersmcintyre @IshratHusain_ Dr. Rodrigo Mansur for their invaluable mentorship and guidance & my colleagues @MDPU_TWH
account_circle
Iain Campbell, Ph.D.(@IainCampbellPhD) 's Twitter Profile Photo

Thanks Roger S. McIntyre, MD, FRCPC for referencing our Lithium and PI3K/Akt Insulin Signalling Paper at .

Lots of interesting new research taking place in this area, including this study showing that an insulin signalling activator 'mimics Lithium's effect in bipolar disorder

Thanks @rogersmcintyre for referencing our Lithium and PI3K/Akt Insulin Signalling Paper at #APA2024.

Lots of interesting new research taking place in this area, including this study showing that an insulin signalling activator 'mimics Lithium's effect in bipolar disorder
account_circle
Kevin Kunzmann(@NotADoctorKevin) 's Twitter Profile Photo

Truly the most fascinating story in medicine has been the evolution of diabetes drug like semaglutide ( ) into new indications.

Here's Roger S. McIntyre, MD, FRCPC explaining how the GLP-1s could possibly treat depression and substance use disorder.

Watch: hcplive.com/view/designing…

account_circle